|
|
Article: Aptagen launches Protein Genesis molecular evolution platform.(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- June 1, 2001
CopyrightCOPYRIGHT 2001 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Aptagen, Inc. (Herndon, VA; 703-793-8000) formally launched its Protein Genesis platform for enhancing and modifying the function of human therapeutic proteins. The announcement was made in light of Aptagen's successful combination of its own Enzyme Evolution technology, which holds the key to creating functional combinations of proteins and enzymes, with technology gained by the recent acquisition of Protein Genesis, Inc. (Tucson, AZ). The newly hybridized technology will possess the unique abilities and advantages of both platforms, such as intracellular evolution and the ability to create mu ti-function protein-based drug products that could not be produced naturally ...